Rapid plaque clearance with anti-amyloid therapy for Alzheimer's disease: in consideration of donanemab treatment duration from real-world cases.

Jeongyeon Hwang; Alison Pietras; Georges Naasan; Fanny M Elahi; Sam Gandy

doi:10.1080/13554794.2026.2730462

SCHEDA SCIENTIFICA2026Caso clinico

Rapid plaque clearance with anti-amyloid therapy for Alzheimer's disease: in consideration of donanemab treatment duration from real-world cases.

Jeongyeon Hwang, Alison Pietras, Georges Naasan, Fanny M Elahi, Sam Gandy

Neurocase · 2026

Psicologia clinica Psicoterapia Neuroscienze Psicologia scolastica Psicodiagnostica

Abstract e pubblicazione originale

L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.

Leggi nella fonte originale ↗

Parole chiave

HumansAlzheimer DiseasePositron-Emission TomographyFemaletau ProteinsMalePlaque, AmyloidBiomarkersAmyloid beta-PeptidesBrainAgedMagnetic Resonance ImagingAntibodies, Monoclonal, HumanizedAlzheimer’s diseaseanti-amyloid therapydonanemabplasma P-tau217treatment durationtreatment response

Come citare questo studio

Jeongyeon Hwang, Alison Pietras, Georges Naasan, Fanny M Elahi, Sam Gandy. (2026). Rapid plaque clearance with anti-amyloid therapy for Alzheimer's disease: in consideration of donanemab treatment duration from real-world cases.. Neurocase. DOI: 10.1080/13554794.2026.2730462

Consulta la pubblicazione originale ↗